Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.
作者信息
Byrne E J, Arie T
机构信息
Department of Health Care of the Elderly, Medical School, Nottingham.
出版信息
BMJ. 1990 Apr 28;300(6732):1132-3; discussion 1131. doi: 10.1136/bmj.300.6732.1132.
Abstract
摘要
相似文献
1
Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.治疗阿尔茨海默病的药物有用吗？2. 缺乏有价值益处的充分证据。
BMJ. 1990 Apr 28;300(6732):1132-3; discussion 1131. doi: 10.1136/bmj.300.6732.1132.
2
[Alzheimer's disease. Biological and pharmacotherapeutic aspects].[阿尔茨海默病。生物学与药物治疗方面]
Fortschr Med. 1986 Jun 19;104(23-24):469-71.
3
Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature.胆碱能增强疗法对阿尔茨海默病记忆功能的影响：文献的荟萃分析
Aust N Z J Psychiatry. 1986 Jun;20(2):237-40. doi: 10.3109/00048678609161337.
4
Treatment of Alzheimer's disease: hopes and reality.阿尔茨海默病的治疗：希望与现实
Can J Neurol Sci. 1991 Aug;18(3 Suppl):439-41. doi: 10.1017/s0317167100032637.
5
Cholinergic approaches to the treatment of Alzheimer's disease.治疗阿尔茨海默病的胆碱能方法。
Br Med Bull. 1986 Jan;42(1):97-100. doi: 10.1093/oxfordjournals.bmb.a072106.
6
Clinical drug trials in Alzheimer's disease.阿尔茨海默病的临床药物试验。
Ann N Y Acad Sci. 1985;444:428-36. doi: 10.1111/j.1749-6632.1985.tb37605.x.
7
Cholinergic drugs in Alzheimer's disease.
N Engl J Med. 1986 Nov 13;315(20):1286-7. doi: 10.1056/NEJM198611133152008.
8
What do we know about Alzheimer's disease today? An overview.如今我们对阿尔茨海默病了解多少？概述。
Dan Med Bull. 1985 Feb;32 Suppl 1:1-21.
9
Treatment of Alzheimer's disease with cholinergic drugs.用胆碱能药物治疗阿尔茨海默病。
Int J Clin Pharmacol Ther Toxicol. 1991 Jan;29(1):23-37.
10
Intracranial drug administration in Alzheimer's disease.阿尔茨海默病的颅内给药
Psychopharmacol Bull. 1986;22(1):106-9.
引用本文的文献
1
Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989.全科医疗中的药物使用：1988年和1989年意大利艾米利亚-罗马涅地区全科医生开具国家处方集药物的习惯
Eur J Clin Pharmacol. 1992;42(4):401-8. doi: 10.1007/BF00280126.
本文引用的文献
1
Effects of 4-aminopyridine in elderly patients with Alzheimer's disease.4-氨基吡啶对老年阿尔茨海默病患者的影响。
N Engl J Med. 1984 Apr 12;310(15):988-9. doi: 10.1056/NEJM198404123101514.
2
Neurochemical characteristics of early and late onset types of Alzheimer's disease.早发型和晚发型阿尔茨海默病的神经化学特征
Br Med J (Clin Res Ed). 1984 Mar 31;288(6422):961-4. doi: 10.1136/bmj.288.6422.961.
3
A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.一项关于高剂量卵磷脂治疗阿尔茨海默病的双盲、安慰剂对照试验。
J Neurol Neurosurg Psychiatry. 1985 Aug;48(8):736-42. doi: 10.1136/jnnp.48.8.736.
4
Agitation associated with dementia: a systematic approach to treatment.
Psychopharmacol Bull. 1988;24(1):49-53.
5
Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.
Psychopharmacol Bull. 1988;24(1):31-8.
6
Pharmacologic treatment of agitation associated with dementia.
J Am Geriatr Soc. 1986 May;34(5):368-76. doi: 10.1111/j.1532-5415.1986.tb04320.x.
7
Efficacy of antipsychotics in the treatment of the behavioral complications of dementia: a review of the literature.抗精神病药物治疗痴呆行为并发症的疗效：文献综述
J Am Geriatr Soc. 1985 Mar;33(3):206-9. doi: 10.1111/j.1532-5415.1985.tb04894.x.
8
The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type.
Br J Psychiatry. 1989 Jun;154:797-800. doi: 10.1192/bjp.154.6.797.
9
Tetrahydroaminoacridine (THA) in Alzheimer's disease.四氢氨基吖啶（THA）与阿尔茨海默病
BMJ. 1989 Apr 1;298(6677):845-6. doi: 10.1136/bmj.298.6677.845.
Zotero 插件